Objective. The aim of this study was to determine the extent to which structural damage, clinical disease activity, demographic and social factors are associated with work disability (WD) in PsA.
Introduction
PsA is a chronic inflammatory arthritis associated with psoriasis. Patients with PsA may have skin and joint disease but may also have manifestations such as enthesitis, axial disease, uveitis, the metabolic syndrome and other less well-defined factors related to long-term inflammation, such as fatigue. All these elements combine to have a significantly detrimental effect on physical function and quality of life [1] . Work is of central importance to patients and it is now well recognized that work disability (WD) is an important, patient-centred quality of life outcome that needs further investigation [2] . WD is an umbrella term encompassing a spectrum of disability including productivity loss and presenteeism (reduced effectiveness at work) through to absenteeism and unemployment.
The existing body of knowledge relating to WD in PsA has been recently reviewed [3] . There is evidence suggesting that levels of unemployment (2050%) and WD (1639%) are high and are associated with longer disease duration, worse physical function, high joint count, low educational level, female sex, erosive disease and manual work. Interpretation of the data is hampered by the small number of reports, the heterogeneity of the data collected and the limitations of post hoc analyses of work data as a secondary endpoint [3] . The current body of evidence comes from either short-duration, highly selected randomized controlled trials with limited generalizability or registry databases relating to employment levels or disability benefit collection.
We set out to determine to what extent structural damage, clinical disease activity and demographic and social factors are associated with employment, absenteeism, presenteeism and productivity loss in PsA using the Work Productivity and Activity Impairment (WPAI) questionnaire [4].
Methods
Long-Term Outcome in Psoriatic Arthritis II (LOPAS II) is a multicentre observational cohort study conceived to explore the associations of WD in PsA and study the effect of drug treatment. Twenty-three sites across England participated in this study. Four hundred patients fulfilling CASPAR (Classification Criteria for Psoriatic Arthritis) commencing a new DMARD or anti-TNF treatment were recruited and baseline data have been used to investigate factors associated with WD. LOPAS II was approved by the South Wales Research Ethics Committee Panel D. All participants signed written consent in accordance with the Declaration of Helsinki.
Demographic information on sex, education, smoking and alcohol use, ethnicity, disease and symptom duration and number and type of co-morbidities was collected using a background information form. The following outcome data were collected at routine clinic visits: physician assessment of disease activity was made with the disease activity in PsA (DAPSA) composite score [summation of 66 swollen and 68 tender joint counts, CRP, patient global and pain visual analogue scale (VAS) scores] [5], patient reported outcomes included physical function with the HAQ, the European Quality of Life Five Dimensions (EQ-5D) questionnaire, Dermatology Life Quality Index (DLQI), global and domain-specific activity VAS scores and the Functional Assessment of Chronic Illness Therapy (FACIT) fatigue scale. WD was assessed with the WPAI, a patient-reported quantitative assessment of the amount of absenteeism, presenteeism, productivity loss and general activity impairment attributable to a specific health problem. Additional work data were collected using a questionnaire designed for this study, including job title (converted into the International Standard Classification of Occupations 2008 (ISCO-08) and employer awareness/helpfulness on a Likert scale. Radiographs of the hands and feet were taken and scored using the PsA Ratingen score [6] .
Statistical analysis
Statistical analysis of demographic data has been undertaken using SPSS version 20 (IBM, Armonk, NY, USA). Associations between potential explanatory variables and unemployment status were examined using multivariate logistic regression and with percentage presenteeism and productivity loss using multivariate linear regression models. The distribution of absenteeism showed small numbers in several categories, so it was converted into a binary variable representing either present (0%) or absent (100%) and analysed using multivariate logistic regression. The regression analyses were undertaken using the statistical package R (R Project for Statistical Computing, Vienna, Austria). All measured variables were considered for inclusion, including location. Age demonstrated a non-linear relationship, therefore a quadratic term was applied. Two-way interactions were considered in all models but no significant effects at this level were observed.
Results
Of the 400 participants, 318 were of UK working age (1865 years), with a mean age of 46.8 years (S.D. 11.02), mean disease duration of 5.8 years (S.D. 8.00) and 49.9% female. Two hundred and twenty-six (64%) of working age participants were in work, with a further 10 over retirement age still working. Ninety-two participants of working age (26%) were unemployed. Comparison of demographic, clinical, radiographic and socio-economic factors of those working (any age) and those not working (1865 years only) are presented in Table 1 . The mean level of absenteeism, presenteeism and productivity loss of the 236 participants in work was 14% (S.D. 29.0), 39% (S.D. 27.2) and 46% (S.D. 30.4), respectively.
Negative influences upon remaining in employment included greater age, disease duration of 25 years and worse physical function (Table 2) Absenteeism as a binary variable (present or absent over the previous week) was associated with a worse joint activity VAS (0100) such that for every increase of 10 on the VAS scale the OR of absenteeism increased by 4% [OR 1.04 (95% CI 1.018, 1.055), P 4 0.01].
Greater global and joint-specific disease activity and worse physical function exerted a negative influence on presenteeism and productivity loss ( Table 2 ). For every increase of 10 in the global disease activity VAS (0100) there was an increase in presenteeism of 2% estimate 0.02 (95% CI 0.001, 0.053), P = 0.01] and 3% for productivity loss [estimate 0.03 (95% CI 0.003, 0.55), P = 0.01]. Worse physical function (HAQ scale 03) was strongly 
Discussion
We report the associations of unemployment, absenteeism, presenteeism and productivity loss among a well-classified cohort of patients with PsA recruited from multiple sites across England.
With regard to unemployment, we report the novel findings that patient-reported employer helpfulness, greater age and recent disease onset are associated with unemployment. The British Society of Rheumatologists Biologics Register (BSRBR) is the only study to date to investigate the influence of age on employment and did not find an association [7] . In this present study the absolute effect of each year of age upon becoming unemployed is small, an increase of 1% for every additional year of age. However, PsA is a chronic disease and when considered over decades this effect becomes a clinically meaningful burden.
The finding in our present study of increased unemployment in those with early disease (25 years' duration) is an interesting one and in keeping with the finding of high levels of unemployment in the first 5 years of RA reviewed by Nikiphorou et al. [8] . Four studies have previously reported that increasing disease duration negatively influences remaining in employment [7, 911] . The findings of this present study of increased unemployment in those with disease duration of 25 years differs from these prior reports and differences in study design may account for this. First, the mean disease duration of patients in this study was 8 years, substantially less than the one other study conducted in the UK, the BSRBR study (14 years) [7] . Second, differing social security systems may influence an individual's decision to stop work and three of the other prior studies were conducted in countries other than the UK: Germany [10] , Norway [11] and Sweden [9] . Finally, we measured relatively short duration absenteeism with the WPAI, which has a recall period of 1 week, whereas other studies were based on government social security benefit collection records and thus measured more long-term absence from work.
To our knowledge this is the first time patient-reported employer helpfulness has been investigated in PsA. We found that employer awareness and helpfulness exerts a positive influence on remaining in employment, even if patients perceive no help is required. This finding emphasizes the multifactorial influences upon WD and the importance of accounting for as many potentially confounding factors as possible. The strength of this association in the regression model may account for variables identified in previous studies, such as worse physical function [7, 11, 12] , joint disease [7, 12, 13] , fatigue [12] , erosive disease [11] , sex [7, 9, 11] and education [10, 11] , not achieving significant associations and subsequent inclusion in the final models. OR: odds ratio; VAS: visual analogue scale. Intercept: represents the odds ratio or estimate when all variables are zero, such that age is zero, disease duration is 01 years, global/joint VAS is zero, HAQ is zero, employer is unaware. Significant associations are shown in bold.
Relating to absenteeism, presenteeism and productivity loss among those at work, we found that only disease activity factors, rather than demographic or socioeconomic factors, influence performance. Specifically in the present study, greater global and joint-specific disease activity and worse physical function exerted a negative influence on presenteeism and productivity loss. Furthermore, disease activity measures appear to exert a greater influence than severity (radiographic damage), which did not achieve inclusion in the final models. This suggests that although there are multiple potential social and economic factors, disease activity remains an important influencing factor.
The finding that global and joint-specific activity but not the domain of skin disease (skin-specific activity VAS score or DLQI) reached statistical significance in the final models is consistent with prior reports comparing patients with PsA and those with psoriasis alone. Two studies have reported increased WD among patients with PsA versus patients with psoriasis alone [14, 15] . To our knowledge this is the first study reporting the relative impact of joint and skin disease on WD and indicates that joint disease exerts the greatest influence in this cohort. It should be noted that the level of skin activity compared with joint activity was low (39% skin VAS versus 62% joint VAS among those not working). By including people with relatively mild skin disease we may have overestimated the relative influence of the joint domain. Nonetheless, the finding in this study that disease activity measures, which are potentially reversible, exert a negative influence on performance at work adds strength to the theory that presenteeism/productivity loss can be improved with treatment.
The findings of this study should be interpreted in the light of certain methodological considerations. First, the 23 recruiting centres were located across England, but did not include London, potentially limiting the generalizability of the results. We did employ a spatial model to assess for geographical variation in WPAI and no differences were detected. Second, we reported low levels of agreement between joint count assessors in this study, which would have reduced our ability to detect any association with WD [16] . Training in joint count assessment was subsequently given to recruiting centres in an attempt to standardize clinical assessment. Finally, it should be noted that the employer helpfulness Likert scale was developed for use in this study and has not been formally validated.
In conclusion, greater age, recent disease onset (25 years' disease duration) and worse physical function exert a negative influence on remaining in employment. Patient-reported employer awareness and helpfulness exert a strongly positive influence on remaining in employment, even if patients perceive no help is required. In contrast, in those who remain at work, reduced effectiveness (presenteeism and productivity loss) is associated with the greater global and joint-specific disease activity VASs and worse physical function. Further prospective study is under way to investigate whether ameliorating disease activity improves absenteeism, presenteeism and productivity loss.
Rheumatology key messages
. Presenteeism and productivity loss are associated with measures of greater PsA disease activity. . Unemployment in patients with PsA is associated with employer helpfulness, age, disease duration and physical function.
